Comparative Proteomic Analysis Identifies Key Metabolic Regulators of Gemcitabine Resistance in Pancreatic Cancer

Pancreatic adenocarcinoma (PDAC) is highly refractory to treatment. Standard-of-care gemcitabine (Gem) provides only modest survival benefits, and development of Gem resistance (GemR) compromises its efficacy. Highly GemR clones of Gem-sensitive MIAPaCa-2 cells were developed to investigate the mole...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Qingxiang, Shen, Shichen, Qian, Zhicheng, Rasam, Sailee S., Serratore, Andrea, Jusko, William J., Kandel, Eugene S., Qu, Jun, Straubinger, Robert M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582795/
https://www.ncbi.nlm.nih.gov/pubmed/36084875
http://dx.doi.org/10.1016/j.mcpro.2022.100409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582795/
https://www.ncbi.nlm.nih.gov/pubmed/36084875
http://dx.doi.org/10.1016/j.mcpro.2022.100409

Ejemplares similares